FGF Signaling Regulates Cytoskeletal Remodeling during Epithelial Morphogenesis  by Sai, XiaoRei & Ladher, Raj K.
Current Biology 18, 976–981, July 8, 2008 ª2008 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2008.05.049
Report
FGF Signaling Regulates
Cytoskeletal Remodeling
during Epithelial MorphogenesisXiaoRei Sai1 and Raj K. Ladher1,*
1Laboratory for Sensory Development
RIKEN Kobe Institute
Center for Developmental Biology
2-2-3 Minatojima-Minamimachi
Chuo-ku, Kobe, 640-0047
Japan
Summary
Changes in the cytoskeletal architecture underpin the dy-
namic changes in tissue shape that occur during develop-
ment [1–4]. It is clear that such changes must be coordinated
so that individual cell behaviors are synchronized; however,
the mechanisms by which morphogenesis is instructed and
coordinated are unknown. After its induction in non-neural
ectoderm, the inner ear undergoes morphogenesis, being
transformed from a flat ectodermal disk on the surface of
the embryo to a hollowed sphere embedded in the head
[5–9]. We provide evidence that this shape change relies
on extrinsic signals subsequent to genetic specification.
By using specific inhibitors, we find that local fibroblast
growth factor (FGF) signaling triggers a phosphorylation
cascade that activates basal myosin II through the activation
of phopholipase Cg. Myosin II exhibits a noncanonical
activity that results in the local depletion of actin filaments.
Significantly, the resulting apical actin enrichment drives
morphogenesis of the inner ear. Thus, FGF signaling directly
exerts profound cytoskeletal effects on otic cells, coordinat-
ing the morphogenesis of the inner ear. The iteration of this
morphogenetic signaling system suggests that it is a more
generally applicable mechanism in other epithelial tissues
undergoing shape change.
Results and Discussion
Otic Morphogenesis Requires Fibroblast Growth
Factor Signaling
The inner ear is induced by a series of interactions initiated by
FGF signaling in the underlying mesoderm [5, 6]. Specifically,
FGF-mediated signaling activates the expression of ‘‘otic’’
genes such as Pax2, Soho1, Dlx5, and Nkx5.1 [5]. In addition
to gene expression, there are morphological consequences
of otic induction; the otic placode undergoes a series of shape
changes that result in the formation of a vesicular otocyst
within the head mesenchyme [7–9]. In brief, after initially thick-
ening, the otic ectoderm invaginates, forming a depression
that deepens into a cup-like structure (Figure S1 available on-
line). Apical constriction then encloses the epithelium to form
a hollowed sphere—the otocyst. One of the earliest features
of otic invagination is a decrease in apical length relative to
basal length of the otic ectoderm. This reflects both basal ex-
pansion and apical constriction. This ratio, or invagination in-
dex (II), enables the progression of inner ear morphogenesis
*Correspondence: raj-ladher@cdb.riken.jpto be accurately represented. At 10 ss (somite stage), the
otic placode has an II of 0.95 (n = 6; Table 1); however, approx-
imately 4–6 hr later at 13 ss, invagination has progressed and
the otic placode shows an II of 0.77 (n = 6; Table 1). The mech-
anisms that transform this initially flat disc of cells into a three-
dimensional structure are not well characterized, and the role
of paracrine factors has never been addressed in depth.
To test the requirement of extrinsic signaling on otic invagi-
nation, we isolated chick otic ectoderm from 10 ss and 13 ss
embryos and cultured for 24 hr (Figure 1). Such isolated ecto-
derm continued to express the otic marker Pax2 [10] (Figures
1B and 1D). However, at 10 ss, isolated otic ectoderm explants
failed to undergo morphogenesis (Figure 1B). In contrast, otic
ectoderm from 13 ss embryos formed vesicular structures
within 24 hr of explantation (Figure 1D). This suggests that
otic morphogenesis requires extrinsic signals.
Previous studies have shown that FGF3 and FGF19 are the
endogenous factors acting from mesoderm and neural ecto-
derm subjacent to the otic placode to mediate otic specifica-
tion [5, 11]. Their continued expression subjacent to the otic
placode at 9–10 ss also makes them good candidates for
factors that regulate invagination. To test this, we isolated
otic ectoderm from 9–10 ss embryos and placed heparin-
acrylic beads soaked in a mixture of FGF3 and FGF19 protein
either basally or apically. After incubation for 24 hr, otic ecto-
derm incubated with BSA-soaked beads failed to invaginate
(only 2/25 cases formed otocysts), although they continued
to express the otic marker Pax2 (Figure 1E). Explants cultured
with apical FGF beads similarly failed to invaginate (0/9;
Figure 1F). Only otic ectodermal explants incubated with ba-
sally applied FGF-soaked beads showed invagination (17/23;
Figure 1G), suggesting a role for FGF signaling in the regulation
of otic morphogenesis.
Apical Actin Localization Is Required for Otic Invagination
Cytoskeletal rearrangement underlies a number of morphoge-
netic events, including gastrulation [12, 13], dorsal closure in
Drosophila [14], and neural tube closure in vertebrates [3,
15]. We hypothesized that changes in cytoskeletal arrange-
ment led to the ability of 13 ss otic ectoderm to autonomously
invaginate and that this change was controlled by FGF signal-
ing. We investigated microtubule and F-actin localization in
otic placode cells. Microtubules are arranged similarly in 10 ss
and 13 ss otic ectoderm (Figures 2A and 2B). In contrast,
Alexa-488 phalloidin revealed a marked difference in the
arrangement of actin filaments. F-actin was detected both
basally and apically at 10 ss (Figure 2A). However, in 13 ss
otic ectoderm, actin filaments are depleted basally, resulting
in the apical polarization of F-actin (Figure 2B).
To test necessity for otic morphogenesis, we explanted the
portion of the embryo between the third rhombomere and sec-
ond somite centered on the otic placode. These otic regions
invaginate normally (II = 0.84; Table 1; Figure 2C). Quantifica-
tion of phalloidin staining intensity allowed actin polarization
to be expressed numerically as a ratio of apical to basal actin
(aa:ba). Such measurement revealed that control otic regions,
cultured for 4 hr, also show normal polarization (aa:ba = 4.85;
Table 1). To determine the effect of disrupting actin dynamics,
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ends of F-actin, cytochalasin D either stabilizes or destabilizes
actin filaments depending on the context [16]. 10 ss otic region
explants incubated with 1 mM cytochalasin D for 4 hr showed
undiminished basal actin, resulting in symmetric F-actin distri-
bution and no significant invagination (aa:ba = 1.09; II = 0.9;
n = 6; Figure S2).
We next used jasplakinolide to disrupt actin dynamics.
Jasplakinolide alters actin kinetics, enhancing both polymeri-
zation and depolymerization processes [17]. Otic regions at
10 ss were explanted and cultured in 1 mM of jasplakinolide
for 4 hr. F-actin staining on the apical side was stronger and
the domain 1.74 times wider than in controls (n = 6; p <
0.005; Figure S2). In contrast, basal phalloidin binding was
Table 1. Relative Apical and Basal F-Actin Staining and Apical-to-Basal
Length of Otic Ectoderm after Inhibitor Treatment
Treatment aa:ba Invagination Index
Control (DMSO) 4.86 6 0.11 0.837 6 0.003
U73343 5.2 6 0.14 0.842 6 0.01
U0126 4.26 6 0.02*** 0.824 6 0.01
Cytochalasin D 1.01 6 0.01* 0.900 6 0.01*
Jasplakinolide 7.67 6 0.074* 0.872 6 0.01**
U71322 1.02 6 0.004* 0.955 6 0.02*
ML-7 0.99 6 0.004* 0.945 6 0.007*
Blebbistatin 1.01 6 0.002* 0.943 6 0.01*
SU5402 1.09 6 0.002* 0.940 6 0.02*
Phalloidin staining was used to determine the amount of apical and basal
F-actin in the otic ectoderm after particular pharmacological treatments.
In each case, at least six different experimental samples were sectioned
and stained. The fluorescent intensity of apical and basal halves of the
otic epithelium was determined by IP lab. In the same samples, apical and
basal lengths of the otic placode were measured; the ratio was used as
an invagination index. Student’s t test was used to determine p values
when compared to the carrier (DMSO) control. *p < 0.005; **p = 0.03;
***p = 0.016. p values less then 0.005 are taken as significant.negligible, suggesting that basal F-actin was not stabilized
by jasplakinolide treatment (aa:ba = 7.67; n = 6; Table 1;
Figure S2). In addition, invagination was not significantly per-
turbed after 4 hr of incubation (II = 0.87; Figure S2).
Jasplakinolide enhances the rate of actin nucleation [17].
Thus, when the rates of actin polymerization and depolymer-
ization are equivalent, the enhanced rate of nucleation causes
the appearance of thicker fibers; this is the case on the apical
side of otic cells. However, in regions where actin filaments un-
dergo a net depolymerization, the effect of jasplakinolide is
negligible. The basal otic placode did not show enhanced actin
localization, so we hypothesized that basal actin filaments
undergo active depolymerization from 10 ss otic ectoderm.
Basal FGF Directs Cytoskeletal Remodeling
through Phospholipase-Cg Activation
Basal actin depolymerization in otic ectoderm suggested
a mechanism by which FGF signals, emanating from basally
apposed mesoderm and neural ectoderm, remodeled the
cytoskeleton. 10 ss otic regions were cultured with SU5402,
a specific inhibitor of FGF signaling, for 4 hr [18]. Such treat-
ment does not affect genetic specification of the otic ectoderm
(Figure S3) [19]. In otic region explants treated with carrier only
(DMSO), actin filaments were apically biased and morphogen-
esis occurred as normal (aa:ba = 4.85; II = 0.84; n = 28; Table 1;
Figure 2C). In contrast, SU5402-treated otic regions showed
loss of apical actin enrichment and a failure to invaginate
(aa:ba = 1.09; II = 0.94; n = 6; Table 1; Figure 2D).
Only basal application of FGF beads could direct morpho-
genesis in 10 ss otic ectoderm isolates (Figures 1E–1G). Addi-
tionally, immunolocalization of FGFR1, the major FGF receptor
in the otic placode at these stages, showed a basal bias, sug-
gesting FGF is transduced basally (Figures 2E and 2F). We thus
investigated mediators of FGF signaling. FGF signaling occurs
through two distinct pathways: a Ras-dependent MAP kinase
pathway [20] and via the phosphorylation of phospholipaseFigure 1. FGF Signaling Is Sufficient for Otic
Morphogenesis
(A) Scanning electron micrographs (SEM)
through the otic region of 10 ss chick embryo.
Otic ectoderm (oe) is in close proximity to neural
tube (nt) and mesoderm (m). Dotted lines here
and in (B) show apical and basal lengths used
to calculate the invagination index.
(B) 10 ss otic ectoderm separated from underly-
ing mesoderm and neuroectoderm cannot un-
dergo morphogenesis, despite showing immu-
noreactivity to Pax2.
(C) SEM through the otic region of 13 ss chick
embryo showing a deepening of the otic placode.
(D) Otic ectoderm isolated from 13 ss embryos
can invaginate and express Pax2 after 24 hr of
culture.
(E–G) 10 ss otic ectoderm, cultured for 24 hr,
does not invaginate after incubation with a BSA-
soaked bead (E) or if cultured with an apically
located FGF-soaked bead (F). However, basal
application of FGF-soaked beads directs mor-
phogenesis (G).
Scale bars represent 20 mm.
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Local Phospholipase Cg Activation
(A and B) Sections through the otic placode at 10 ss and 13 ss show apical
and basal actin filaments (green) at 10 ss (A). By 13 ss, F-actin is enriched
apically and depleted basally (B). In both cases, microtubules (magenta)
are longitudinal and cortical.
(C) Explants of 10 ss otic regions show normal apical actin polarization
(green) and invagination of otic ectoderm.
(D) Treatment of 10 ss otic region with the FGF receptor inhibitor SU5402
inhibits actin (green) polarization and ectodermal invagination.
(E and F) FGFR1 can be detected basally within the 10 ss otic placode (E).
Higher magnification reveals a minor domain in apically located vesicles (F).
(G) Phosphorylated phospholipase Cg (pPLCg; green) is found on the basal
side of the 10 ss otic placode, with a minor domain found in apically located
vesicles (arrowhead).
(H) Activation of PLCg is sensitive to FGF receptor signaling; inhibition with
SU5402 in 10 ss otic regions inhibits PLCg phosphorylation.
(I) 10 ss otic regions incubated with U73343 develop normally, showing actin
polarization (F-actin; green) and good morphogenesis after culture for 8 hr.
(J) In 10 ss otic regions cultured for 8 hr with U73122, F-actin is not apically
polarized and otic invagination is perturbed.
In all panels, nuclei are marked in blue by the DNA stain DAPI. Abbreviations:
apical, a; basal, b; otic ectoderm, oe; neural tube, nt. Scale bars represent
20 mm.C gamma (PLCg) [21]. Double phosphorylated Erk1/2 was de-
tected in 10 ss otic ectoderm nuclei, but treatment of the 10 ss
otic region with the MEK1/2 inhibitor U0126 only slightly al-
tered F-actin localization and did not significantly inhibit invag-
ination (aa:ba = 4.26; II = 0.84; n = 10; Table 1; Figure S4). We
detected phosphorylated (and therefore active) PLCg at the
basal side of otic placode cells (Figure 2G). The basal localiza-
tion of pPLCg suggested activation by basal FGF signals. This
was confirmed by treatment of 10 ss otic regions with SU5402.
Phospho-PLCg immunoreactivity was diminished in such
treated otic regions (n = 6; Figure 2H).
Activated PLCg affects the membrane translocation of
typical protein kinase C (PKC). PKCa was detected basally in
the 10 ss otic placode (Figure S5), reminiscent of the distribu-
tions of FGFR1 and phosphorylated PLCg. A specific PLCg in-
hibitor, U73122, caused a diminution of juxtamembrane PKCa
immunoreactivity (n = 5; Figure S5). In contrast, the inactive
isomer U73343, used as a negative control, did not affect
PKC localization.
We investigated the possibility that PLCg, acting through
PKCa, leads to the asymmetric distribution of F-actin in otic
placode cells. Actin polarization and otic invagination was
lost in 10 ss otic regions treated with U73122 (aa:ba = 1.02;
II = 0.95; n = 7; Table 1; Figure 2J). These data strongly suggest
that localized PLCg activation by FGF causes depletion of
actin fibers on the basal side of the otic placode.
Myosin II Activity Depletes Basal Actin in Placodal
Ectoderm
We next explored the downstream mechanism by which FGF-
mediated PLCg activation led to depletion of actin filaments
from the basal side of the otic placode. Actin depolymerization
factors (ADF) mediate the depolymerization of actin filaments
[22]. However, we were unable to detect cofilin, a major ADF,
on basal otic placode (Figure 3A). We next inspected the acti-
vation of myosin II. Canonically, myosin II mediates actin fila-
ment contraction; however, recently a noncanonical activity
has been described. Myosin II is involved in the clearance of
actin filaments in the transition zone of neuronal growth cones
[23] and in cortical actin turnover during cytokinesis [24, 25]. In
addition, direct visualization of myosin II causing purified actin
filaments to depolymerize provides compelling evidence for
this activity [26, 27]. Nonmuscle myosin II is active only when
the regulatory light chain is phosphorylated [28]. By using an
antibody specific to phosphorylated myosin light chain
(MLC), we found that active myosin II, similar to pPLCg, is
localized predominantly to the basal side of the 10 ss otic
ectoderm (Figure 3B).
To investigate the role of myosin II in actin localization
and thus otic invagination, we used blebbistatin, a specific
inhibitor of myosin II motor activity [29]. In 10 ss otic regions
incubated with blebbistatin, both actin polarization and otic in-
vagination were inhibited (aa:ba = 1.01; II = 0.94 6 0.02; n = 7;
Table 1; Figure 3D). This suggested that myosin II activity is
required for F-actin depletion on the basal side of the otic
placode.
To determine whether myosin light chain phosphorylation
was responsible for the depolymerizing activity of myosin II,
we incubated 10 ss otic region in an inhibitor of myosin light
chain kinase, ML-7 [30]. ML-7 at a concentration of 20 mM ef-
fectively reduced the phosphorylation of myosin light chain
(MLC) (Figure 3F). In addition, phalloidin staining revealed
that actin was not polarized and invagination inhibited (aa:ba =
0.99; II = 0.95 6 0.01; n = 6; Table 1; Figure 3F).
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(A) The actin depolymerization factor cofilin is localized to the apical side of the embryonic ectoderm at 10 ss.
(B) Phosphorylated myosin light chain (pMLC; green) is found on the basal side of the chick otic placode at stage 10, with a minor domain on apically located
vesicles (arrowhead).
(C) Control otic regions explanted from 10 ss embryo express Pax2 (magenta) with clear apical F-actin (green) polarization and extensive morphogenesis
after 4 hr in culture.
(D) When cultured for 4 hr with the myosin II inhibitor blebbistatin, 10 ss otic regions continue to express the otic marker Pax2 (magenta). However, apical
actin (green) polarization is not generated and the ectoderm fails to undergo morphogenesis.
(E) 10 ss control (carrier) otic regions show basal myosin light chain phosphorylation (magenta) and apical F-actin (green) polarization, when cultured for 4 hr.
Individual channels are depicted to the right of this panel for greater clarity.
(F) 10 ss otic regions treated with the myosin light chain kinase inhibitor ML-7 for 4 hr show a reduction in MLC phosphorylation (magenta) and a disruption of
actin polarization (green). Individual channels are depicted to the right of this panel for greater clarity.
In (B) and (E), nuclei are marked by the DNA stain DAPI in blue. Scale bars represent 20 mm.FGF Signaling Regulates Myosin II Activity
We hypothesized that myosin light chain phosphorylation was
regulatedbyFGFsignaling.Phosphorylationofmyosin lightchain
was not detected in 10 ss otic regions treated with SU5402 (n = 6;
Figure 4B). Similarly, MLC phosphorylation is inhibited in 10 ss
otic regions incubated with the PLCg inhibitor U73122 (n = 7;
Figure 4C). Neither of these treatments affected the pattern of
the nonregulatory myosin II heavy chain (Figures 4B and 4C).
To determine whether the activation of myosin II and the re-
sulting apical actin polarization was a primary response to FGF
signaling, we used 10 ss otic ectoderm isolates to test whether
this regulation is direct. Otic ectoderm explants at 10 ss were
pretreated with 5 mM cycloheximide, an inhibitor of translation.
Such treatment reduces new protein synthesis to less then 5%
of control conditions. Cycloheximide-treated explants were
then incubated with FGF3 and FGF19 and cultured for 4 hr.
In explants treated with cycloheximide alone, actin filaments
are evenly distributed and the phosphorylation of myosin light
chain cannot be detected (Figures 4D and 4E). Measurements
of the length of each face of the explant (analogous to our use
of the invagination index) detected an II = 0.876 0.01 (n = 6). In
contrast, 10 ss otic ectoderm explants, treated with 5 mM
cycloheximide and FGF3+19 protein, show asymmetric actin
localization, significant myosin light chain phosphorylation,
and significant morphogenesis (II = 0.76 6 0.01; n = 6; Figures
4F and 4G). These results suggest that the activation of myosin
II and reorganization of F-actin by FGF signaling is direct and
does not require any new protein synthesis.
Taken together, these results place FGF signaling at the
head of a PLCg-mediated cascade that directly leads to the
activation of myosin II. Myosin II activity causes the depoly-
merization of basal actin filaments, leading to apical actin
enrichment that is required for otic morphogenesis.Conclusions
The involvement of actin and myosin in the closure of the neu-
ral plate and during Drosophila mesodermal invagination has
been well documented [31–36], and in these cases F-actin
and myosin II have been shown to colocalize and are thought
to drive apical constriction. This is true during later inner ear
morphogenesis [37], but during the earliest morphogenetic
steps described here, F-actin and active myosin II are on
opposite sides of the otic cell. Indeed, such a reciprocal local-
ization can be detected in the early neural tube, even though
during later morphogenesis colocalization is observed
(Figure S6). Similarly, during the earliest steps of Drosophila
gastrulation, myosin II is initially basal and its localization ap-
pears to be concomitant with basal F-actin loss and apical
actin enrichment in the invaginating mesoderm [12, 34]. The
signaling mechanisms that underlie these steps are still un-
clear, but recent data suggest the involvement of FGF receptor
signal transduction in the closure of the neural tube, indepen-
dent of any effect on cell fate specification [38].
Taken together, these observations raise the intriguing
possibility that the coordination of tissue morphogenesis by
receptor signaling, through the activation of myosin II, may de-
scribe a general mechanism that underpins the cytoskeletal
changes associated with epithelial morphogenesis.
Supplemental Data
Six figures and Experimental Procedures are available at http://www.
current-biology.com/cgi/content/full/18/13/976/DC1/.
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